Press Room

Press release

Duchesnay USA Applauds Expanded Coverage for Treatments for Dyspareunia due to Menopause under Medicare Part D

Read more >
Press release

Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Osphena® (ospemifene) to U.S. FDA

Read more >
Press release

Duchesnay USA Continues the Morning Sickness Conversation with Actress, Mom and Singer Jana Kramer and Beverly Hills Ob/Gyn Dr. Jay Goldberg

Read more >
Press release

Duchesnay Inc. to Present a Poster on Adherence, Persistence and Healthcare Costs Associated with Ospemifene at 2018 Annual Meeting of the North American Menopause Society (NAMS)

Read more >
Press release

Duchesnay Inc. to Present a Poster on Ospemifene at the 2018 Annual Meeting of the North American Menopause Society (NAMS)

Read more >
Press release

Duchesnay Inc. to Present a Poster on the Efficacy and Safety of Ospemifene in Menopausal Women with Moderate to Severe Vaginal Dryness at 2018 Annual Meeting of the North American Menopause Society (NAMS)

Read more >